Daré Bioscience Reports Results for Quarter Ended June 30, 2026

What Happened
Daré Bioscience, Inc. (DARE) announced its financial results for the quarter ended June 30, 2026. The company issued a press release on August 13, 2026, reporting its quarterly operating and financial results; that press release is furnished as Exhibit 99.1 to the Form 8-K filed the same day under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: August 13, 2026 (Form 8-K).
• Period covered: quarter ended June 30, 2026.
• Disclosure: press release furnished as Exhibit 99.1 to the 8-K.
• Additional exhibit: Exhibit 104 (Inline XBRL cover page) included with the filing.

Why It Matters
Quarterly results give investors updated information on the company's earnings, revenue, cash position and overall financial condition—key factors that can affect valuation and near-term outlook. This Form 8-K furnishes the press release but does not add other SEC items (e.g., executive changes or material agreements). Retail investors should read the press release (Exhibit 99.1) for the specific figures (revenue, net income/loss, cash runway, and any guidance) to assess Daré’s recent performance.